THE United States' Food & Drug Administration has found a widely used asthma drug binds to brain receptors, affecting psychiatric functions.
Researchers found significant quantities of Montelukast in patients' brain receptors, which govern mood, impulse, and more, Reuters reported.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Nov 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Nov 24
